Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James U Adelman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Headache|November 25, 2003
Meta-analysis methodology: the battle continuesJonathan Belsey, James U Adelman
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hoursJames U Adelman, Jonathan Belsey
Neurology|March 9, 2005
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraineJames U Adelman, Anne Calhoun
Headache|January 9, 2008
Electronic medical record system in a headache specialty practice: a patient satisfaction surveyMarshall C Freeman, Anne P Taylor, James U Adelman
Journal of Occupational and Environmental Medicine|November 12, 2005
The effect of early intervention with sumatriptan tablets on migraine-associated productivity lossW Jacqueline Kwong, Frederick R Taylor, James U Adelman
Headache|September 22, 2007
Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart reviewAnne P Taylor, James U Adelman, Marshall C Freeman
Headache|November 28, 2002
Cost-effectiveness of antiepileptic drugs in migraine prophylaxisJames U Adelman, Leon C Adelman, Randal Von Seggern
Headache|October 23, 2002
Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysisRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|February 6, 2004
Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trialRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|November 25, 2003
Does migraine preventive medication actually reduce resource utilization?James U Adelman, Leon C Adelman, Randal L Von Seggern, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Headache|November 25, 2003
Meta-analysis methodology: the battle continuesJonathan Belsey, James U Adelman
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hoursJames U Adelman, Jonathan Belsey
Neurology|March 9, 2005
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraineJames U Adelman, Anne Calhoun
Headache|January 9, 2008
Electronic medical record system in a headache specialty practice: a patient satisfaction surveyMarshall C Freeman, Anne P Taylor, James U Adelman
Journal of Occupational and Environmental Medicine|November 12, 2005
The effect of early intervention with sumatriptan tablets on migraine-associated productivity lossW Jacqueline Kwong, Frederick R Taylor, James U Adelman
Headache|September 22, 2007
Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart reviewAnne P Taylor, James U Adelman, Marshall C Freeman
Headache|November 28, 2002
Cost-effectiveness of antiepileptic drugs in migraine prophylaxisJames U Adelman, Leon C Adelman, Randal Von Seggern
Headache|October 23, 2002
Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysisRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|February 6, 2004
Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trialRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|November 25, 2003
Does migraine preventive medication actually reduce resource utilization?James U Adelman, Leon C Adelman, Randal L Von Seggern, et al.
Pageof 2